<unk>  <unk> -DHET; developmental code name HE-3562) is an active metabolite of the formerly clinically used but now-discontinued progestin ethisterone and the experimental and never-marketed hormonal antineoplastic agent ethynylandrostanediol (HE-3235). Its formation from its parent drugs is catalyzed by<unk> -reductase in tissues that express the enzyme in high amounts like the liver, skin, hair follicles, and prostate gland.<unk> -DHET has significant affinity for steroid hormone receptors and may contribute importantly to the activities of its parent drugs.
5α-Dihydroethisterone
3α-Androstanediol
3β-Androstanediol
8,9-Dehydroestradiol
17β-Dihydroequilin
8,9-Dehydroestrone
17α-Dihydroequilin
17β-Dihydroequilenin